Archives: Agenda

During the roundtable discussion session, the conference hall will be divided into three ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical supply chains. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1: Developing comprehensive organizational approaches to interactive response technology (IRT) for efficient supply management
Chris Silva, Vice President, Supply Chain, Procurement and Sourcing, Akebia Therapeutics

ROUNDTABLE 2: Exploring ways of advancing clinical trial supply with RPA, Advanced Analytics and Generative AI
Tomasz Adamusiak, Chief Scientist, Clinical Quality and Data Science, MITRE

ROUNDTABLE 3: Developing a proper Supply Chain and Logistics department in Clinical Phase 1 and 2 with a focus on commercial launch implications
Sebastian Tomlin, Director, Distribution and Logistics, Cullinan Therapeutics
Eric Elbel, Former Associate Director, Logistics, Geron Corporation

• Understanding the pharmacy card model
• The program lifecycle: from design to delivery
• A day in the life: sponsor & sites
• Proof of performance: feedback and case studies

• How Bluefin’s proprietary digital twin architecture enables RTSM integration and accurate, real-time forecasting
• Case study: Accurately forecasting a close call as enrollment accelerates
• Case study: Explaining high overage driven by short shelf-life – turning a stakeholder question into a data story

• Benefits and components of patient-centric model
• Current challenges including patients and researchers perspectives
• Implementation and AI tools

• Examining patient and site perceptions of direct-to-participant investigational product shipments
• Understanding how decentralized distribution models influence engagement, site workload and data integrity
• Exploring how AI is supporting trial design, operational efficiency and decision-making across the study lifecycle

Accelerate, cultivate, innovate!

• Managing relationships with the modern supplier
• How Bayer’s external relationship governance model adds value to the business ensuring a reliable partnership and complements the sourcing & procurement functions within CTS scope
• Trends on procurement roles and the necessity to have an operational perspective
• Different approaches from different business necessities
• Trends on how to best manage CMOs, 3PLs and clinical trials partners

• Strengthening inspection readiness through audit-ready documentation and traceability
• Mitigating risk through robust deviation and excursion management
• Enhancing compliance through strong vendor oversight and team preparedness

• Forecasting: testing RTSM resupply algorithms to reduce waste and prevent stockouts
• Real-time control: Monitor your trial in real time and react quickly to changes
• A key data source for forecasting: Use RTSM data to improve clinical demand accuracy over time